| Literature DB >> 28291809 |
Rashan Haniffa1, Yoel Lubell1,2, Ben S Cooper1,2, Sanjib Mohanty3, Shamsul Alam4, Arjun Karki5, Rajya Pattnaik3, Ahmed Maswood4, R Haque4, Raju Pangeni5, Marcus J Schultz6, Arjen M Dondorp1,2.
Abstract
OBJECTIVE: To assess the impact on ICU performance of a modular training program in three resource-limited general adult ICUs in India, Bangladesh, and Nepal.Entities:
Mesh:
Year: 2017 PMID: 28291809 PMCID: PMC5349661 DOI: 10.1371/journal.pone.0173483
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demography, clinical profile, severity of illness and ICU discharge status of patients in the three ICUs admitted during the before and after commencement of training period.
| Pre-intervention | Post-intervention | |||||
|---|---|---|---|---|---|---|
| Site | Rourkela | Chittagong | Patan | Rourkela | Chittagong | Patan |
| 822 | 103 | 122 | 1777 | 616 | 293 | |
| 49.7(0 .5–95) | 39.7(7–96) | 54.3(9–95) | 49.6(1.5–95) | 36.6(10days-98) | 49.8(12–90) | |
| 69.80% | 65.40% | 50% | 68.90% | 49.50% | 44.40% | |
| 24.7(7.5) | 13.8(6.4) | 9.2(5.9) | 24.5(7.9) | 12.7(5.9) | 9(5.7) | |
| 0.125(0.13) | 0.162(0.146) | 0.121(0.102) | 0.124(0.125) | 0.182(0.152) | 0.123 (0.112) | |
| 228(28%) | 64(62%) | 50(41%) | 525(30%) | 313(51%) | 53(18%) | |
* probability
Fig 1Common admission diagnoses (APACHE II diagnostic category) and mortality by site during study period.
Fig 2Cumulative incidence function for ICU mortality in the three study sites.
P-values refer to the evidence for stepwise changes in adjusted subdistribution hazard ratio from the Fine-Gray model for the cumulative incidence of ICU mortality.
Trends for outcomes in the three study sites.
| Cumulative incidence of ICU mortality aSHR (95% CI) | ICU mortality rate aHR (95% CI) | ICU discharge alive rate aHR (95% CI) | Rate of stopping mechanical ventilation aHR (95% CI) | Rate of stopping vasoactive drugs aHR (95% CI) | Rate of stopping antibiotics aHR (95% CI) | |
| 0.99(0.98–1.01),p = 0.55 | 1.01(0.99–1.03),p = 0.55 | 1.01(1.00–1.02),p = 0.07 | 1(0.97–1.04),p = 1.00 | 0.93(0.880.98),p = 0.01 | 0.99(0.96–1.01),p = 0.30 | |
| 1.17(0.75–1.82),p = 0.49 | 0.96(0.61,1.51),p = 0.87 | 0.9(0.70–1.15),p = 0.40 | 0.94(0.45–1.93),p = 0.86 | 2.45(0.76–7.88),p = 0.13 | 0.56(0.32–1.00),p = 0.05 | |
| 1.01(0.99–1.03),p = 0.50 | 1(0.98–1.02),p = 0.68 | 0.99(0.98–1.00),p = 0.06 | 1.01(0.97–1.04),p = 0.69 | 1.08(1.03–1.14),p = 0.002 | 0.99(0.98–1.01),p = 0.55 | |
| Cumulative incidence of ICU mortality aSHR (95% CI) | ICU mortality rate aHR (95% CI) | ICU discharge alive rate aHR (95% CI) | Rate of stopping mechanical ventilation aHR (95% CI) | Rate of stopping vasoactive drugs aHR (95% CI) | Rate of stopping antibiotics aHR (95% CI) | |
| 1.02(1.00–1.04),p = 0.03 | 1.01(0.99–1.03),p = 0.51 | 0.99(0.97–1.02),p = 0.47 | 0.96(0.93–1.00),p = 0.03 | 0.99(0.95–1.04),p = 0.77 | 0.98(0.92–1.04),p = 0.49 | |
| 0.62(0.40–0.97),p = 0.04 | 0.9(0.54–1.49),p = 0.69 | 1.6(0.85–3.02),p = 0.15 | 2.97(1.24–7.14),p = 0.02 | 1.2(0.43–3.35),p = 0.72 | 1.26(0.27–5.91),p = 0.77 | |
| 0.98(0.96–1.00),p = 0.03 | 0.99(0.97–1.01),p = 0.55 | 1.01(0.99–1.04),p = 0.34 | 1.04(1.01–1.08),p = 0.01 | 1.01(0.97–1.06),p = 0.59 | 1.04(0.98–1.10),p = 0.23 | |
| Cumulative incidence of ICU mortality aSHR (95% CI) | ICU mortality rate aHR (95% CI) | ICU discharge alive rate aHR (95% CI) | Rate of stopping mechanical ventilation aHR (95% CI) | Rate of stopping vasoactive drugs aHR (95% CI) | Rate of stopping antibiotics aHR (95% CI) | |
| 1.02(1.00–1.05),p = 0.08 | 1.01(0.99–1.04),p = 0.38 | 0.99(0.97–1.00),p = 0.11 | 1(0.97–1.02),p = 0.90 | 1.01(0.97–1.06),p = 0.60 | 1.01(0.98–1.04),p = 0.42 | |
| 0.16(0.06–0.41),p<0.001 | 0.22(0.08–0.62),p = 0.004 | 1.87(1.02–3.43),p = 0.04 | 1.95(0.51–7.4),p = 0.33 | 2.04(0.45–9.16),p = 0.36 | 1.85(0.82–4.18)p = 0.14 | |
| 1(0.96–1.03),p = 0.82 | 1.01(0.97–1.04),p = 0.69 | 1.01(0.99–1.03),p = 0.23 | 0.99(0.95–1.03),p = 0.70 | 0.98(0.93–1.04),p = 0.57 | 0.98(0.95–1.01),p = 0.24 | |
aHR, adjusted hazard ratio; aSHR, adjusted sub-distribution hazard ratio
1 Results are based on the competing risks regression, which accounts for the effect of the intervention. aSHR is the adjusted sub-distribution hazard ratio, adjusting for sex, age, reason, APACHE II probability, and whether the patient is a medical admission.
2 Results are based on a Cox regression model
3 Time units are expressed in weeks, so reported aSHR and aHR represent proportional change in outcome each week
Fig 3Median duration of ICU stay, mechanical ventilation, vasoactive drug use and antibiotic use in the three study sites by four-week period.
The trend line is a non-parametric locally weighted scatterplot smoother. The vertical line indicates the time that the training intervention started.